Post-Cycle Considerations: What Happens When You Stop

The off block is where cycling earns its keep. It's also the part most people mishandle — either by panicking at week-one dropoff, by doubling back in too early, or by treating it as a dead zone instead of an active recovery phase.

What actually happens when you stop depends on the compound. Some clear in hours. Some continue working for weeks. Some leave your endogenous system quieter than it was before you started.

The three things that change when you stop

1. Blood levels drop according to half-life. Fast compounds (Ipamorelin, minutes) are gone in an afternoon. Slow compounds (TB-500, DAC-modified, Semaglutide) linger for weeks.
2. Receptor expression normalizes. Downregulated receptors gradually return to baseline. This is what the off block is for.
3. Endogenous output returns. Your own pituitary pulses, your own repair signals, your own appetite and satiety. How fast depends on how suppressed they got.

Typical post-cycle timelines

Compound	Effect tail	Endogenous recovery
BPC-157	~1–2 days	Not suppressive; recovery is about tissue integration
TB-500	2–4 weeks (long half-life)	Not suppressive
Ipamorelin	Hours	GH axis normalizes within days
CJC-1295 no-DAC	~1 day	Pituitary normalizes within 1–2 weeks
CJC-1295 DAC	1–2 weeks	2–4 weeks for full pituitary normalization
MK-677	~1–2 days	Insulin sensitivity, prolactin normalize within 2–4 weeks
Semaglutide	5–7 weeks	Appetite rebound usually builds over first 4–8 weeks off
Tirzepatide	3–5 weeks	Similar rebound window to semaglutide
PT-141	Hours	Not applicable (acute use)

What to expect in the first week off

• No obvious change for long-tail compounds. If you ran TB-500, you're still "on" pharmacologically. Don't chase effects.
• Sleep might shift with GHS. Many users report sleep quality dipping the first few days after stopping an Ipamorelin-style protocol. Usually normalizes within 1–2 weeks.
• Appetite rebound on GLP-1s. Often the biggest behavior shift. Doesn't appear day one — typically builds over weeks 2–6 as drug levels fall.
• Joint/healing work keeps integrating. BPC-157 and TB-500 effects often continue improving for weeks post-cycle as the tissue finishes remodeling.

What to do during the off block

• Keep sleep and nutrition tight. Recovery leans on them entirely now.
• Don't immediately "bridge" with a different peptide. Receptor families overlap. Bridging Ipamorelin into GHRP-2 isn't a real off block for the ghrelin receptor.
• Log changes. Energy, sleep, hunger, training output. This is your data for next cycle.
• Bloodwork if you ran anything long or suppressive. IGF-1 before and after a long GHS cycle, fasting glucose and HbA1c after MK-677 or GLP-1s, CBC and metabolic panel for general runs.

When to start the next cycle

General rule: the off block should be long enough that you can answer "what changed when I stopped?" If you can't tell, you went back on too early.

Specific guidance:

Previous block	Minimum off
4–6 weeks healing protocol	2–4 weeks
8–12 weeks GHS	4 weeks minimum, 6 is better
12+ weeks MK-677	4–8 weeks, bloodwork-driven
Long GLP-1 run	Clinical context, not "cycled" — tapered down slowly

Common mistakes

• Jumping back in at week two because you "feel flat." Week two is usually peak dropoff. Week four is where you see true baseline.
• Treating TB-500 as gone at the end of the dosing block. It isn't. Your real "off" starts 2–4 weeks after last injection.
• Stopping a GLP-1 cold turkey. Appetite rebound is sharper. Taper the dose down over 2–4 weeks instead.
• No post-cycle bloodwork on long GHS runs. If IGF-1 is sitting low for months, you want to know.
• Immediately starting a different-class peptide "to not lose progress." Gains you keep after an honest off block are yours. Gains that vanish in two weeks weren't real adaptations.

Where to go next

• How to plan the next "on" block: cycling principles.
• Bloodwork-relevant compounds: Pepperpedia pharmacology pages.
• Post-cycle experiences: Protocol Discussions forum.